Skip to main content

Table 1 Lymphocyte subsets of the two groups at enrolment

From: Naïve CD4+ cell counts significantly decay and high HIV RNA levels contribute to immunological progression in long-term non-progressors infected with HIV by blood products: a cohort study

  DG non-DG  
(N = 6) (N = 19) p
CD19 + B counts (cells/uL) 164 (94–215) 160 (142–206) 0.799
CD19 + B percentage(%) 8.75 (5.68–13.6) 9.9 (7.8–12.9) 0.525
CD16CD56 + NK counts (cells/uL) 250 (153–315) 137 (82–178) 0.092
CD16CD56 + NK percentage (%) 13.5 (7.1–19.2) 8.8 (5.1–10.4) 0.143
CD3+ T counts (cells/uL) 1048 (924–1717) 1367 (1166–1536) 0.340
CD3+ T percentage (%) 71.2 (64.6–78.2) 79.9 (75.7–83.7) 0.011
CD3 + CD4 + T counts (cells/uL) 440 (432–616) 510 (472–572) 0.105
CD3 + CD8 + T counts (cells/uL) 574 (358–1184) 733 (570–856) 0.445
CD4 + CD45RA-(cells/uL) 225 (211–337) 291 (233–367) 0.181
CD4 + CD45RA + CD62L+(cells/uL) 212 (193–279) 188 (154–259) 0.408
CD8 + HLA-DR+/CD8 + (%) 36.9 (25.8–59.7) 32.6 (26.6–45.0) 0.408
CD8 + CD38/CD8 + (%) 62.1 (52.2–70.5) 48.0 (37.3–59.0) 0.03
CD4/CD8 0.76 (0.41–1.7) 0.75 (0.55–0.97) 0.949